Inquiry Basket
Elebsiran, an antiviral agent against hepatitis B and D virus infections, is a small interfering RNA (siRNA) therapeutic designed to target and silence specific mRNA sequences responsible for the production of pathogenic proteins. Its mechanism of action involves the degradation of targeted mRNA, thereby preventing the synthesis of proteins that contribute to disease progression.